Literature DB >> 21841372

Chronic conditions more than age drive health system use in Canadian seniors.

Michael Terner1, Ben Reason, Ali Moses McKeag, Brenda Tipper, Greg Webster.   

Abstract

Which has more impact on health status and the use of healthcare services among seniors: age or the number of chronic conditions? To answer this question, we used responses from the 2008 Canadian Survey of Experiences with Primary Health Care to assess the effect of these two factors on seniors' self-perceived health status, prescription medication use and healthcare service use. We discovered that seniors with at least three chronic conditions were more likely to report poor health, take more prescription medications and use more healthcare services than seniors with two or fewer chronic conditions. The number of chronic conditions is better than age as a predictor of self-reported health status, prescription medication use and healthcare service use by seniors. Seniors with at least three conditions represented 24% of all seniors, but they accounted for 40% of the use of healthcare services. Health policies and programs focused on the prevention and improved management of co-morbidities among seniors could have a significant and positive impact on seniors' health (including self-perceived health status) and their use of healthcare services.

Mesh:

Year:  2011        PMID: 21841372     DOI: 10.12927/hcq.2011.22485

Source DB:  PubMed          Journal:  Healthc Q        ISSN: 1710-2774


  18 in total

1.  A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012.

Authors:  Rachael Morkem; David Barber; Tyler Williamson; Scott B Patten
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

2.  The expanding scope of pharmacists' practice: implications for physicians.

Authors:  Cara Tannenbaum; Ross T Tsuyuki
Journal:  CMAJ       Date:  2013-08-19       Impact factor: 8.262

3.  Sex and gender considerations in Canadian clinical practice guidelines: a systematic review.

Authors:  Cara Tannenbaum; Barbara Clow; Margaret Haworth-Brockman; Patrice Voss
Journal:  CMAJ Open       Date:  2017-02-10

4.  Increasing comorbidity and health services utilization in older adults with prior stroke.

Authors:  Andrea Gruneir; Lauren E Griffith; Kathryn Fisher; Dilzayn Panjwani; Sima Gandhi; Li Sheng; Chris Patterson; Amiram Gafni; Jenny Ploeg; Maureen Markle-Reid
Journal:  Neurology       Date:  2016-10-19       Impact factor: 9.910

5.  Should hospital pharmacy departments commit a larger proportion of their clinical resources to ambulatory and primary care services?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2012-11

6.  Patient-Centred Innovations for Persons with Multimorbidity: funded evaluation protocol.

Authors:  Moira Stewart; Martin Fortin
Journal:  CMAJ Open       Date:  2017-05-09

7.  Perspectives of specialists and family physicians in interprofessional teams in caring for patients with multimorbidity: a qualitative study.

Authors:  Pauline Boeckxstaens; Judith Belle Brown; Sonja M Reichert; Christopher N C Smith; Moira Stewart; Martin Fortin
Journal:  CMAJ Open       Date:  2020-04-06

8.  A pilot study examining the unmet needs of cancer survivors living with polypathology.

Authors:  M Siu; P Catton; J Jones; A R Jadad
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

9.  Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation.

Authors:  Roopinder K Sandhu; Lisa M Guirguis; Tammy J Bungard; Erik Youngson; Lisa Dolovich; Jamie C Brehaut; Jeff S Healey; Finlay A McAlister
Journal:  Can Pharm J (Ott)       Date:  2017-11-29

10.  A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial.

Authors:  Philippe Martin; Robyn Tamblyn; Sara Ahmed; Andrea Benedetti; Cara Tannenbaum
Journal:  Trials       Date:  2015-06-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.